Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research.

Hye Won KimSeong Ryul KwonKyong-Hee JungSeong-Kyu KimHan Joo BaekMi Ryung SeoSo-Young BangHye-Soon LeeChang-Hee SuhJu Yang JungChang-Nam SonSeung Cheol ShimSang-Hoon LeeSeung-Geun LeeYeon-Ah LeeEun Young LeeTae-Hwan KimYong-Gil Kimnull null

Published in: PloS one (2016)

Instances of tuberculosis were treated successfully in our AS patients, even when given concomitantly with TNF inhibitors. We suggest that early resumption of TNF inhibitors in AS patients could be safe under effective coverage of tuberculosis.

Keyphrases

end stage renal disease
ankylosing spondylitis
newly diagnosed
ejection fraction
rheumatoid arthritis
chronic kidney disease
peritoneal dialysis
mycobacterium tuberculosis
healthcare
emergency department
pulmonary tuberculosis
patient reported outcomes
disease activity
hepatitis c virus